The board of directors of the US pharmaceutical company Silo Pharma approved the purchase of 1 million dollars worth of Bitcoin as reserve assets.

On June 5, GlobeNewswire reported that the U.S.-listed pharmaceutical company Silo Pharma (Nasdaq: SILO) The board of directors has approved the purchase of bitcoin worth up to $1 million as a reserve asset. Silo Pharma CEO Eric Weisblum said the inclusion of Bitcoin in the company’s reserves is a strategic decision that will diversify assets through a digital store of value and serve as a safeguard against inflation, a move that Silo Pharma expects will optimize long-term shareholder value.

BTC-0.11%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin